体重指数与手术方式对子宫内膜癌及子宫内膜增生患者手术并发症与费用的影响
基于MarketScan理赔数据库2008至2014年1112例因子宫内膜癌或增生手术的患者,比较不同体重指数(BMI)组和手术方式的30天并发症与费用。BMI≥40组静脉血栓栓塞和伤口感染率更高,此差异由开腹手术亚组驱动,微创手术组未见;BMI≥40组中位总费用与较低BMI组无显著差异,但各BMI组开腹手术费用均高于微创手术,病态肥胖组差值最大。结论认为微创手术可能通过减少并发症和降低费用提高医疗价值,在病态肥胖女性中可能最明显。
要点
- BMI≥40组静脉血栓栓塞发生率3%,高于BMI 30-39组的0.2%和BMI≤29组的0.3%(p<0.01)。
- BMI≥40组伤口感染发生率7%,高于BMI 30-39组的3%和BMI≤29组的3%(p=0.02)。
- 上述并发症增加仅见于开腹手术亚组,微创手术亚组未见。
核心结论
- 微创手术可能通过减少并发症和降低费用提高医疗价值,在病态肥胖女性中可能最明显。
研究设计与样本
- 利用MarketScan医疗理赔数据库识别2008至2014年因子宫内膜癌或子宫内膜增生接受手术且有BMI数据的全部女性,共1112例。
- 按BMI分组(≤29、30-39、≥40 kg/m2)比较30天并发症和费用,并按手术方式分层。
主要发现
- 1112例中BMI≤29、30-39、≥40 kg/m2者分别占35%、36%、29%。
- BMI≥40组静脉血栓栓塞发生率3%,高于BMI 30-39组的0.2%和BMI≤29组的0.3%(p<0.01)。
- BMI≥40组伤口感染发生率7%,高于BMI 30-39组的3%和BMI≤29组的3%(p=0.02)。
- BMI≥40、30-39、≤29组中位总费用分别为17.3千美元、16.8千美元、16.6千美元(p=0.53)。
- 各BMI组开腹手术费用均高于微创手术,病态肥胖组差值最大(≥40:21.6千美元 vs 14.9千美元,p<0.01;30-39:18.9千美元 vs 16.1千美元,p=0.01;≤29:19.3千美元 vs 15千美元,p<0.01)。
临床怎么用
- 原文结论指出微创手术可能通过减少并发症和降低费用提高医疗价值,在病态肥胖女性中可能最明显。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the impact of body mass index (BMI) and operative approach on surgical morbidity and costs in patients with endometrial carcinoma (EC) and hyperplasia (EH). METHODS: All women with BMI data who underwent surgery for EC or EH from 2008 to 2014 were identified from MarketScan, a healthcare claims database. Differences in 30-day complications and costs were compared between BMI groups and stratified by surgical modality. RESULTS: Of 1112 patients, 35%, 36%, and 29% had a BMI of ≤29, 30-39, and ≥40kg/m2, respectively. Compared to patients with a BMI of 30-39 and ≤29, women with a BMI ≥40 had higher rates of venous thromboembolism (3% vs 0.2% vs 0.3%, p<0.01) and wound infection (7% vs 3% vs 3%, p=0.02). This increase was driven by the subset of patients who had laparotomy and was not seen in those undergoing minimally invasive surgery (MIS). Median total costs for women with a BMI ≥40, 30-39, and ≤29 were U.S. $17.3k, $16.8k, and $16.6k respectively (p=0.53). Costs were higher for patients who had laparotomy than those who had MIS across all BMI groups, with the cost difference being highest in morbidly obese women (≥40: $21.6k vs $14.9k, p<0.01; 30-39: $18.9k vs $16.1k, p=0.01; ≤29: $19.3k vs $15k, p<0.01). Patients who had complications had higher costs compared to those who did not, with a higher cost difference in the laparotomy group ($27.7k vs $16.4k, p<0.01) compared to the MIS group ($19.9k vs $15k, p<0.01). CONCLUSIONS: MIS may increase the value of care by minimizing complications and decreasing costs. This may be most pronounced in morbidly obese women.
引用
- Suidan RS, He W, Sun CC, et al. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol. 2017. PMID: 28131529. doi:10.1016/j.ygyno.2017.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。